top of page

Vision Statement

We strive for a future where the simple act of walking is a given

DSCF1775_stent2_edited.jpg

What We Do

Expanding treatment options for lower limb ischemia with a stent capable of accessing small-diameter blood vessels.

Global Vascular has developed a drug-eluting stent (DES) delivery system for lower limb artery disease, achieving the world’s first cutting-edge endovascular therapy using nanotechnology.

News

BioStealth™ Stent and Its Three Core Technologies

BioDiamond™ Technology

Ultra-durable diamond nano-coating with excellent blood compatibility* and endothelial affinity**. It is biologically invisible—recognized as native, not foreign, minimizing adverse reactions in the body.

BioGradia™ Technology

A smart, active biodegradable polymer coating that gradually releases drug during the critical healing phase. Once its job is done, it naturally dissolves, leaving nothing behind.

Thin Force™ Technology

An advanced stent structure that is both ultra-thin and highly expandable.
This innovative design defies convention, achieving flexibility and radial strength in perfect harmony.

References

*: T. Saito, T. Hasebe, S. Yohena, et al., Antithrombogenicity of fluorinated diamond-like carbon films, Diam. Relat. Mater. (2005)
**: Y. Yoshimoto, T. Hasebe, S. Nagashima, et al., Human umbilical vein endothelial cell interaction with fluorine-incorporated amorphous carbon films, Jpn. J. Appl. Phys. (2012)

References

私たちは「歩く」という当たり前が世界中の人々にとって享受しつづけられるよう
最新の治療を患者さんに一日でも早くお届けすることを使命とし、日々挑戦を続けています。

人々の暮らしをより良くする挑戦を、私たちと共に始めてみませんか。

Our Partners

ロゴ-08.png
ロゴ2-10.png
ロゴ2-05.png
ロゴ-13.png
Logo-03.png
yamashina.png
AMED_EN.png
img_logo_header.png
img_logo_header.png
JS_logo_02.png

Company Profile

Company Name

Global Vascular Co., Ltd.

Representative

Kenta BITO, Shunto MAEGAWA

Founded

12/12/2022

Capital

90,000,000JPY

Head office

Ichigaya Science and Technology Innovation Center Building 2F, 3-8 Ichigayatamachi, Shinjuku-ku, Tokyo, 162-0843, JAPAN

Tokyo office

mirio Jimbocho 11F, 28-1 Kanda-Jimbocho 1-chome, Chiyoda-ku, Tokyo, 101-0051, JAPAN

Business description

Research and development of medical equipment, research, consulting, etc.

Investor

Diamond Medino Capital Inc.

TANAKA Precious Metals

FAST TRACK INITIATIVE, Inc.

TOKYO UNIVERSITY OF SCIENCE INNOVATION CAPITAL

Mitsubishi UFJ Capital Co., Ltd.

Tokyo University of Science Investment Management Co., Ltd.

Yamashina Seiki Co.,Ltd.

bottom of page